Author: Jennifer Kahn
March 2006
As many as half of all clinical trials are already conducted in locations far from the pharmaceutical companies' home base, in countries like India, China, and Brazil. And many industry analysts expect the market to skyrocket, particularly as expanding libraries of genetic information increase the number of drugs coming out of the lab.
There's a new outsourcing boom in South Asia - and a billion people are jockeying for the jobs. How India became the global hot spot for drug trials.
Saudi Arabia on the Edge
A leading Middle East scholar pens this "good introduction to the Saudi paradox of social change and political stability and an invaluable guide to the challenges the country faces." More
American Force
An investigation of the use of American force since the end of the Cold War. More
The Struggle for Egypt
A sweeping account of Egypt in the modern era: what Egypt is, what it stands for, and its relation to the world. More
Saudi Arabia in the New Middle East
Gause posits that, though the Arab Awakening has caused tensions in Saudi-American relations, the two countries do not face a crisis and still have significant mutual interests that should be prioritized.
Partners in Preventive Action
The authors assess the strengths and weaknesses of international institutions and provide a set of practical recommendations for how the United States can strengthen the global architecture for preventive action by partnering with those organizations.
A compilation of resources on the impact of the global financial crisis on South Asia.
Jagdish Bhagwati and Rajeev Kohli make the case for proposed reforms to India's retail sector that would allow the entry of retail giants...
This report tracks the foreign investment portfolios of the BRIC governments— Brazil, Russia, India, and China—by looking at reserves...
Print
Email
Share
